Disease Management for Coronary Artery Patients

NACompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

December 30, 2019

Study Completion Date

March 30, 2020

Conditions
Patient EmpowermentCoronary Artery Disease
Interventions
OTHER

Patient education

"The data collection process of the study was carried out in two stages using data collection tools.~First stage: Personal Information Form and Compliance Questionnaire were applied to all patients in both groups. After anthropometric measurements, Framingham Risk Score was determined. The data collection forms were filled with the patients using face-to-face interview technique. The data collection process lasted for approximately 10-15 minutes. After the data collection, the patients in the intervention group were trained. No training was given to the patients in the control group but they received a Coronary Artery Disease Management Guide.~Second stage: 12 weeks after the first interview, the patients were interviewed again face-to-face interview technique and the forms and measurements applied initially were repeated."

Trial Locations (1)

79100

Kilis 7 Aralık University, Kilis

All Listed Sponsors
lead

Kilis 7 Aralik University

OTHER

NCT04556006 - Disease Management for Coronary Artery Patients | Biotech Hunter | Biotech Hunter